Format

Send to

Choose Destination
Clin Chem Lab Med. 2008;46(1):27-42.

Critical evaluation of 1H NMR metabonomics of serum as a methodology for disease risk assessment and diagnostics.

Author information

1
Laboratory of Computational Engineering, Systems Biology and Bioinformation Technology, Helsinki University of Technology, Espoo, Finland. mika.ala-korpela@hut.fi

Abstract

This review focuses on (i) the current status of 1H NMR spectroscopy to quantify lipoprotein subclasses directly from serum or plasma, and (ii) the applications of 1H NMR metabonomics of serum in biomedicine. Related to both themes, experimental and data analysis methodologies are discussed together with the biochemical rationales. Particular emphasis is placed on the concepts of risk assessment and diagnostics in relation to the potential clinical role of 1H NMR metabonomics; recent applications in the area of coronary heart disease and diabetes are addressed in more detail.

PMID:
18020967
DOI:
10.1515/CCLM.2008.006
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Sheridan PubFactory
Loading ...
Support Center